Assembly Biosciences

ASMBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$508.404 M

$24.97 -1.46%

Close of 18 Sept 2026

Revenue

$72.3M

#2611 by revenue

Earnings

-$6.12M

Loss-making

Shares outstanding

20,360,596

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#205KamadaKMDA$510.7M
#206Contineum TherapeuticsCTNM$509.0M
#207Assembly BiosciencesASMB$508.4M
#208Puma BiotechnologyPBYI$495.6M
#209VogenxVOGX$482.8M

What if Assembly Biosciences were worth as much as…

Open the what-if tool →

Gold $30.4T

$1,492,464

Per share 59,770× higher

Bitcoin $1.64T

$80,352.65

Per share 3,218× higher

Nvidia $5.36T

$263,091.86

Per share 10,536× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Assembly Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.